scispace - formally typeset
L

Lindvi Gudmundsdotter

Researcher at Karolinska Institutet

Publications -  29
Citations -  732

Lindvi Gudmundsdotter is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Vaccination & Immune system. The author has an hindex of 15, co-authored 27 publications receiving 695 citations. Previous affiliations of Lindvi Gudmundsdotter include Swedish Institute.

Papers
More filters
Journal ArticleDOI

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.

TL;DR: This study investigates intradermal DNA electrovaccination in detail and describes the effects on expression of the vaccine antigen, plasmid persistence and the local tissue environment, finding that the combination of DNA and electroporation induced a significant up-regulation of pro-inflammatory genes.
Journal ArticleDOI

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

TL;DR: A novel strategy for affinity maturation of Affibody molecules that is based on alanine scanning followed by design of library diversification to mimic the result from an error-prone PCR reaction, but with full control over mutated positions and thus less biases is explored.
Journal ArticleDOI

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.

TL;DR: It is demonstrated that plasmids persist in the skin at the site of injection for at least four months after immunization, and no association between plasmid DNA and genomic DNA could be detected as analyzed by qPCR following field inversion gel electrophoresis separating heavy and light DNA fractions.
Journal ArticleDOI

Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension

TL;DR: An alternative format for bispecific molecules was designed and investigated, in which two Affibody molecules were linked by an albumin‐binding domain (ABD) and showed simultaneous binding to the three target proteins (HER2, HER3, and albumin) when investigated in biosensor assays.